From Bowditch to beta-blockers: evolution of the understanding of the importance of heart rate and myocardial energetics in cardiomyopathy - with reference to : a comparison of stimulation frequency and electro-augmentation on myocardial function, extensibility, coronary flow rate, oxygen consumption and glucose metabolism.
During the past three decades, every aspect of cardiomyopathy has undergone dramatic change. When examining the literature on the physiological aspects of the failing heart, one immediately recognises that South Africa has made a contribution: Brink, Bester and Lochner evaluated the possible therapeutic aspects of the Bowditch phenomenon and myocardial energetics in cardiomyopathy almost four decades ago, at a time when the condition even had another name, myocardiopathy.
Ker
J
J
Department of Physiology, University of Pretoria, Pretoria. jker@wol.co.za
D000319:Adrenergic beta-Antagonists / Q000266:history* / Q000627:therapeutic use; D000818:Animals; D009202:Cardiomyopathies / Q000188:drug therapy / Q000266:history* / Q000503:physiopathology; D004734:Energy Metabolism; D006339:Heart Rate; D049673:History, 20th Century; D006801:Humans; D009206:Myocardium / Q000378:metabolism*; D013019:South Africa
D000319:Adrenergic beta-Antagonists